Skip to Content



Please Visit:;jsessionid=7C8924494C5C0B292B91F7A2CDE669FF.wb_javapub_1?protocolList=&protocol=Brain%2FCentral+Nervous+System&ageGroup=A




Title: Chiari Surgery Outcomes Study                                        
Investigator: Bermans Iskandar, MD                                 
Study Sponsor: American Syringomyelia and Chiari Alliance Project Inc.                     

A research project collecting pilot data to evaluate surgical approaches and outcomes in surgery for patients with Chiari type I malformation and syringomyelia.  The study will collect data on the characteristics of subjects who ultimately undergo surgical intervention.  Dr. Iskandar and the University of Wisconsin School of Medicine and Public Health will be the coordinating center collecting and compiling data from 12 clinical sites across the United States.  



Title:  Structural Stability of Carotid Plaque and Symptomatology                                                
Principal Investigator: Robert Dempsey, MD                   
Sponsor: National Institutes of Health

A research project looking at the differences in the plaque in people with symptomatic and asymptomatic carotid stenosis (narrowing of the carotid arteries).  The study uses various techniques to look at the differences in people who have carotid stenosis and the causes and consequences of carotid stroke.


Title: Researching AXIUM™ Coiling Experience and Recanalization (RACER) Study                                         
Principal Investigator: David Niemann, MD            
Study Sponsor:  ev3 Neurovascular

The ev3 Researching AXIUM™ Coiling Experience and Recanalization (RACER) Study is a single arm, prospective, non-randomized, US multi-center study surveying the continuing safety and effectiveness of AXIUM Coils for the treatment of intracranial saccular aneurysms that have a maximum diameter of 2mm to 20mm and are not amenable to treatment with surgical clipping.





Title:A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Progesterone in Patients with Severe Traumatic Brain Injury (SyNAPSe)
Principal Investigator: Joshua Medow, MD
Sponsor: BHR Pharma, LLC       

The goal of the SyNAPSe trial will study if giving intravenous (i.v.) progesterone within 8 hours of the injury for a total of 120 hours to severe traumatic brain injury patients improves their recovery.



Additional Information:
Please contact:
OCT 608.265.6507
Stephanie Wilbrand 608.265.9248


Last updated: Thu, 01/29/2015 - 14:32
Copyright © 2011 The Board of Regents of the University of Wisconsin System